Clinical experience of switching from glargine or neutral protamine Hagedorn insulin to insulin detemir in type 2 diabetes: Observations from the Indian cohort in the A(1)chieve study

AIM: To explore the clinical safety and effectiveness of insulin detemir (IDet) in a subgroup of Indian patients with type 2 diabetes (T2D) switched from either insulin glargine (IGlar) or neutral protamine Hagedorn (NPH) insulin in the 24-week, non-interventional A(1)chieve study. MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Wangnoo, Subhash Kumar, Ghosal, Samit, Akhtar, Shahid, Shetty, Raman, Tripathi, Sudhir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171898/
https://www.ncbi.nlm.nih.gov/pubmed/25285292
http://dx.doi.org/10.4103/2230-8210.139239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171898/
https://www.ncbi.nlm.nih.gov/pubmed/25285292
http://dx.doi.org/10.4103/2230-8210.139239

Ejemplares similares